🧪 Bio Medica Laboratories IPO Subscription Day 1 — 21 May 2026
The Bio Medica Laboratories IPO opened for subscription today on 21 May 2026 on NSE SME. This Indore-based injectable pharma manufacturer is raising ₹52.43 crore at ₹132–₹139 per share. Issue closes 25 May, allotment 26 May, listing 29 May 2026.
📊 Day 1 Subscription Status — Category Wise
• Overall Subscription: Day 1 data for Bio Medica Laboratories IPO subscription is at early stage. Initial bids trickling in.
• Retail (RII) Category: Retail bids being recorded. Issue undersubscribed — allotment probability higher for Day 1 applicants.
• NII / HNI Category: Initial NII participation recorded. HNIs typically bid on Day 2–3.
• QIB Category: QIB quota 50%. Institutional bids expected on final day. Track on IPOView live tracker.
• IPOView Assessment: Lead manager Narnolia has strong track record — last 10 listings showed 19–90% listing gains. Watch Day 3 for full picture.
📈 Bio Medica Laboratories IPO GMP Today — 21 May 2026
The Bio Medica Laboratories IPO GMP today is ₹2 (+1.44%), indicating modest grey market interest. Expected listing price ~₹141. Track live on IPOView GMP Tracker.
📋 IPO Key Details
• Exchange: NSE SME | Price Band: ₹132–₹139 | Issue Size: ₹52.43 Cr
• Lot Size: 1,000 shares | Min. Investment: ₹2,78,000 (2 lots)
• Open: 21 May | Close: 25 May | Allotment: 26 May | Listing: 29 May 2026
• Registrar: Skyline Financial Services | Lead Manager: Narnolia Financial Services
🏭 About Bio Medica Laboratories Ltd
Bio Medica Laboratories, incorporated August 2015, Indore, MP. Manufactures parenteral pharma formulations — liquid injectables, dry powder injectables — for human and veterinary healthcare. B2B contract manufacturing model. GMP + GLP certified facilities.
Disclaimer: Not investment advice. Read RHP carefully. GMP is unofficial and unregulated.